Abstract
Objectives
In patients with locally advanced rectal carcinoma (LARC), negative nodal status after neoadjuvant chemoradiotherapy (nCRT) may allow for rectum-sparing protocols rather than total mesorectal excision; however, current MRI criteria for nodal staging have suboptimal accuracy. The aim of this study was to compare the diagnostic accuracy of different MRI dimensional criteria for nodal staging after nCRT in patients with LARC.
Materials and methods
Patients who underwent MRI after nCRT for LARC followed by surgery were retrospectively included and divided into a training and a validation cohort of 100 and 39 patients, respectively. Short-, long-, and cranial-caudal axes and volume of the largest mesorectal node and nodal status based on European Society of Gastrointestinal Radiology consensus guidelines (i.e., ESGAR method) were assessed by two radiologists independently. Inter-reader agreement was assessed in the training cohort. Histopathology was the reference standard. ROC curves and the best cut-off were calculated, and accuracies compared with the McNemar test.
Results
The study population included 139 patients (median age 62 years [IQR 55–72], 94 men). Inter-reader agreement was high for long axis (κ = 0.81), volume (κ = 0.85), and ESGAR method (κ = 0.88) and low for short axis (κ = 0.11). Accuracy was similar (p > 0.05) for long axis, volume, and ESGAR method both in the training (71%, 74%, and 65%, respectively) and in the validation (83%, 78%, and 75%, respectively) cohorts.
Conclusion
Accuracy of the measurement of long axis and volume of the largest lymph node is not inferior to the ESGAR method for nodal staging after nCRT in LARC.
Clinical relevance statement
In MRI restaging of rectal cancer, measurement of the long axis or volume of largest mesorectal lymph node after preoperative chemoradiotherapy is a faster and reliable alternative to ESGAR criteria for nodal staging.
Key Points
• Current MRI criteria for nodal staging in locally advanced rectal cancer after chemo-radiotherapy have suboptimal accuracy and are time-consuming.
• Measurement of long axis or volume of the largest mesorectal lymph node on MRI showed good accuracy for assessment of loco-regional nodal status in locally advanced rectal cancer.
• MRI measurement of the long axis and volume of largest mesorectal lymph node after chemo-radiotherapy could be a faster and reliable alternative to ESGAR criteria for nodal staging.
Similar content being viewed by others
Abbreviations
- ADC:
-
Apparent diffusion coefficient
- DWI:
-
Diffusion-weighted imaging
- ESGAR:
-
European Society of Gastrointestinal and Abdominal Radiology
- ESMO:
-
European Society of Medical Oncology
- IQR:
-
Interquartile ranges
- LARC:
-
Locally advanced rectal cancer
- nCRT:
-
Neoadjuvant chemoradiotherapy
- NPV:
-
Negative predictive value
- PPV:
-
Positive predictive value
- TME:
-
Total mesorectal excision
- TSE:
-
Turbo spin echo sequences
- VIBE:
-
Volumetric interpolated breath-hold examination
References
Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ (2019) MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics 39(2):367–387
Marchegiani F, Palatucci V, Capelli G et al (2022) Rectal sparing approach after neoadjuvant therapy in patients with rectal cancer: the preliminary results of the ReSARCh Trial. Ann Surg Oncol 29(3):1880–1889
Barina A, De Paoli A, Delrio P et al (2017) Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study. Tech Coloproctol 21(8):633–640
Dossa F, Chesney TR, Acuna SA, Baxter NN (2017) A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2(7):501–513
Cerdán-Santacruz C, Vailati BB, São Julião GP, Habr-Gama A, Perez RO (2022) Watch and wait: why, to whom and how. Surg Oncol 43:101774
Wei MZ, Zhao ZH, Wang JY (2020) The diagnostic accuracy of magnetic resonance imaging in restaging of rectal cancer after preoperative chemoradiotherapy: a meta-analysis and systematic review. J Comput Assist Tomogr 44(1):102–110
Borgheresi A, De Muzio F, Agostini A et al (2022) Lymph nodes evaluation in rectal cancer: where do we stand and future perspective. J Clin Med 11(9):2599
Horvat N, El Homsi M, Miranda J, Mazaheri Y, Gollub MJ, Paroder V (2023) Rectal MRI interpretation after neoadjuvant therapy. J Magn Reson Imaging 57(2):353–369
Beets-Tan RGH, Lambregts DMJ, Maas M et al (2018) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28(4):1465–1475
Zhuang Z, Zhang Y, Wei M, Yang X, Wang Z (2021) Magnetic resonance imaging evaluation of the accuracy of various lymph node staging criteria in rectal cancer: a systematic review and meta-analysis. Front Oncol 11:709070
Ogura A, Konishi T, Cunningham C et al (2019) Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg 154(9):e192172
Lambregts DMJ, Bogveradze N, Blomqvist LK et al (2022) Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus. Eur Radiol 32(7):4991–5003
Sluckin TC, Couwenberg AM, Lambregts DMJ et al (2022) Lateral lymph nodes in rectal cancer: do we all think the same? A review of multidisciplinary obstacles and treatment recommendations. Clin Colorectal Cancer 21(2):80–88
Bossuyt PM, Reitsma JB, Bruns DE et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Radiology 277(3):826–832
Glynne-Jones R, Wyrwicz L, Tiret E et al (2017) ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(4):iv22–iv40
Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal cancer, version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(7):874–901
Haak HE, Beets GL, Peeters K et al (2021) Prevalence of nodal involvement in rectal cancer after chemoradiotherapy. Br J Surg 108(10):1251–1258
Pomerri F, Crimì F, Veronese N et al (2017) Prediction of N0 irradiated rectal cancer comparing MRI before and after preoperative chemoradiotherapy. Dis Colon Rectum 60(11):1184–1191
Beets-Tan RG, Lambregts DM, Maas M et al (2012) Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 23(9):2522–2531
Heijnen LA, Maas M, Beets-Tan RG et al (2016) Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging? Int J Colorectal Dis 31(6):1157–1162
van Heeswijk MM, Lambregts DM, Palm WM et al (2016) DWI for assessment of rectal cancer nodes after chemoradiotherapy: is the absence of nodes at DWI proof of a negative nodal status? AJR Am J Roentgenol 208(3):W79–W84
Kroon HM, Hoogervorst LA, Hanna-Rivero N et al (2022) Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer. Eur J Surg Oncol 48(7):1475–1482
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Prof. Emilio Quaia.
Conflict of interest
Dr. Federica Vernuccio served as Junior Deputy Editor for European Radiology. She has not taken part in the review or selection process of this article. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
Prof. Cristina Campi, Associate Professor in the Department of Mathematics at University of Genova, Italy, performed statistical analysis and is co-author of the paper.
Informed consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethical approval
Institutional Review Board approval was obtained. Local ethical committee of University Hospital of Padua approved the study (protocol number 326N/AO/23, approved on January 19, 2023).
Study subjects or cohorts overlap
No cohorts overlap.
Methodology
• retrospective
• diagnostic study
• performed at one institution
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Crimì, F., Cabrelle, G., Campi, C. et al. Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method. Eur Radiol (2023). https://doi.org/10.1007/s00330-023-10265-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00330-023-10265-3